Montecito Bank & Trust’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Montecito Bank & Trust’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75,717	Closed	-$19K	–	180
2017 Q1	$19K	Hold	75,717	–	–	0.01%	182
2016 Q4	$26K	Hold	75,717	–	–	0.01%	321
2016 Q3	$41K	Hold	75,717	–	–	0.02%	168
2016 Q2	$44K	Hold	75,717	–	–	0.02%	173
2016 Q1	$111K	Hold	75,717	–	–	0.05%	170
2015 Q4	$242K	Hold	75,717	–	–	0.11%	151
2015 Q3	$473K	Hold	75,717	–	–	0.26%	73
2015 Q2	$558K	Hold	75,717	–	–	0.28%	75
2015 Q1	$558K	Hold	75,717	–	–	0.28%	75
2014 Q4	$405K	Buy	+75,717	New	+$387K	0.21%	96

Other funds holding NWBO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Montecito Bank & Trust's NWBO Position: Q2 2017 in Review

Montecito Bank & Trust sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2017, closing a stake of 75,717 shares — an estimated $19K sold.

Montecito Bank & Trust first reported a position in NWBO in Q4 2014 and held it in 10 quarters. The position peaked at $558K in Q2 2015. 2 funds tracked by Wall St. Rank hold NWBO as of Q2 2017.

Montecito Bank & Trust reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2017 after selling out during the quarter.
Montecito Bank & Trust sold 75,717 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2017, an estimated $19K.
Montecito Bank & Trust first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2014 and held it in 10 quarters.
Montecito Bank & Trust's Northwest Biotherapeutics, Inc. Common stock position peaked at $558K in Q2 2015.
2 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2017.

Based on Montecito Bank & Trust's 13F filing for Q2 2017, filed 26 Jul 2017.